BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan
· Delayed Price · Currency is TWD 26.25
+0.05 (0.19%)
Apr 24, 2025, 1:17 PM CST
BioGend Therapeutics Revenue
In the year 2024, BioGend Therapeutics had annual revenue of 167.65M TWD with 52.53% growth. BioGend Therapeutics had revenue of 50.58M in the quarter ending December 31, 2024, with 27.81% growth.
Revenue
167.65M
Revenue Growth
+52.53%
P/S Ratio
19.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.26B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |